Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Stavanger University Hospital

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Stavanger University Hospital (Stavanger Universitetssjukehus or SUS) is one of the country's largest acute care hospitals and the central medical facility for Rogaland county. The hospital operates on an annual budget of approximately 5 billion NOK, employing nearly 8,000 healthcare professionals from more than 30 countries across 130 specialized occupational groups. As a major teaching and research hub, SUS integrates clinical trials and commercial research into its operations while maintaining academic partnerships with the University of Stavanger and the University of Bergen

Business Status

Source: Google. OPEN

Business Category

Source: Google. Hospital

Business Subcategory

Source: Google. Hospital
Source: Trial-derived.
34Total Trials
Source: Trial-derived.
11Recruiting Trials
Source: Trial-derived.
20Active Trials
Source: Trial-derived.
9Completed Trials
Source: Trial-derived.
74Unique Conditions
Source: Trial-derived.
85Unique Sponsors

Conditions

Source: Trial-derived. Acute Myeloid Leukemia (2)Source: Trial-derived. Antiphospholipid Syndrome (APS) (2)Source: Trial-derived. Behçet's Syndrome (BS) (2)Source: Trial-derived. Bullous Pemphigoid (BP) (2)Source: Trial-derived. Death (2)Source: Trial-derived. Dermatomyositis (DM) (2)Source: Trial-derived. Fluid Overload (2)Source: Trial-derived. Heart Failure (2)

Sponsors

Source: Trial-derived. Helse Stavanger HF (8)Source: Trial-derived. Oslo University Hospital (5)Source: Trial-derived. Stichting Hemato-Oncologie voor Volwassenen Nederland (4)Source: Trial-derived. Haukeland University Hospital (3)Source: Trial-derived. Merck Sharp & Dohme LLC (3)Source: Trial-derived. Pfizer (3)Source: Trial-derived. Centre for Research in Intensive Care (CRIC) (2)Source: Trial-derived. Chugai Pharmaceutical (2)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Echocardiography
Source: AI-inferred. Optical coherence tomography (OCT)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Intensive care (ICU)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Fundus examination
Source: AI-inferred. Minimal residual disease testing
Source: AI-inferred. Participant mobile study app (eDiary/ePRO)